By Corey Mann Cowen Healthcare Investments (CHI) is breaking headlines after raising $492 million for a third healthcare fund. The fundraising began well before the coronavirus outbreak in America. A Securities and Exchange Commission (SEC) filing shows Cowen had already raised $332 million as of September 2019.
This fund will enhance the company’s investment strategy into biotech, digital health, drug development and diagnostics. With Cowen’s previous two funds, it’s backed 38 private healthcare companies and has participated in series B rounds other businesses. This includes Semma Therapeutics, a stem cell therapy company that was bought for close to $1 billion in 2019.
What is Cowen …read more
